Bone Regeneration Product Line
Segmental bone defects, particularly in Wounded Warriors and the aging population, reduce health-related quality of life and result in significant healthcare costs. KeraNetics is developing a controlled release carrier system capable of providing physiologically relevant doses of bone growth factors. In pre-clinical models, this system has demonstrated superior bone repair and regeneration compared to currently available treatments.
Pre-Clinical Models Show:
- Delivery vehicle for bone growth factor with improved release kinetics compared to market leaders
- Degradation rate and release profile can be tailored to match a variety of regenerating bone types